心脏表达功能性CASQ1及其缺陷与恶性高热样心律失常的因果关联
研究首次证实CASQ1在心脏表达并调控肌浆网钙释放与心率,Casq1敲除小鼠在2%异氟烷暴露下出现心动过速和室性心动过速,可被丹曲林缓解,机制涉及Casq1寡聚化减弱其对RyR2的抑制,从而揭示一种新的遗传性心律失常及MH/EHS心律失常发生机制。
要点
- CASQ1在人心肌表达,与RyR2物理互作并抑制其活性。
- Casq1缺陷小鼠在2%异氟烷下出现MH/EHS样室性心律失常,丹曲林可缓解。
- 2%异氟烷或41°C加热诱导Casq1寡聚化,减弱Casq1/RyR2互作并增加RyR2活性。
核心结论
- Casq1在心脏表达并调控肌浆网钙释放与心率,其缺陷独立导致MH/EHS样室性心律失常。
研究设计与样本
- 采用常规全身性(Casq1-KO)和心脏特异性(Casq1-CKO)Casq1敲除小鼠,在体内和离体工作心脏分别进行ECG和电标测监测。
- 使用2%异氟烷诱导MH,腹腔注射丹曲林治疗;分离小鼠心肌细胞及新生大鼠心室肌细胞进行活细胞钙成像。
- 通过交联Western blot分析Casq1和Casq2的构象变化;在新生大鼠心室肌细胞中实施Casq1基因敲低、过表达或截短。
主要发现
- Casq1-KO和Casq1-CKO小鼠基础心率增快,暴露于2%异氟烷后出现室性心动过速,丹曲林可缓解。
- 离体Casq1-KO心脏出现基础窦性心动过速和心室异位电触发。
- Casq1-CKO小鼠心室肌细胞在异氟烷下出现丹曲林敏感的钙波和舒张期早发钙瞬变/振荡增加。
- 新生大鼠心室肌细胞Casq1敲低后异氟烷下自发性钙火花/瞬变增强,过表达则减少,C端9个氨基酸截短则丧失该效应。
- 2%异氟烷或41°C加热诱导小鼠心室和骨骼肌组织Casq1寡聚化,减少Casq1/RyR2互作并增加心室RyR2活性。
临床怎么用
- 对MH/EHS事件后出现心律失常的患者,可考虑评估CASQ1功能缺陷作为潜在遗传性心律失常病因。
- 丹曲林可能用于缓解Casq1缺陷相关的MH/EHS样室性心律失常,但需临床研究验证。
- 避免使用异氟烷等触发药物在疑似CASQ1相关心律失常患者中可能有益。
局限性
- 主要证据来自小鼠模型和新生大鼠心室肌细胞,人体数据仅限于CASQ1在心肌表达的观察。
- 未提供CASQ1突变患者心律失常的临床队列数据。
- 丹曲林对Casq1缺陷相关心律失常的疗效尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Calsequestrins (Casqs), comprising the Casq1 and Casq2 isoforms, buffer Ca2+ and regulate its release in the sarcoplasmic reticulum of skeletal and cardiac muscle, respectively. Human inherited diseases associated with mutations in CASQ1 or CASQ2 include malignant hyperthermia/environmental heat stroke (MH/EHS) and catecholaminergic polymorphic ventricular tachycardia. However, patients with an MH/EHS event often experience arrhythmia for which the underlying mechanism remains unknown. METHODS: Working hearts from conventional (Casq1-KO) and cardiac-specific (Casq1-CKO) Casq1 knockout mice were monitored in vivo and ex vivo by ECG and electric mapping, respectively. MH was induced by 2% isoflurane and treated intraperitoneally with dantrolene. Time-lapse imaging was used to monitor intracellular Ca2+ activity in isolated mouse cardiomyocytes or neonatal rat ventricular myocytes with knockdown, overexpression, or truncation of the Casq1 gene. Conformational change in both Casqs was determined by cross-linking Western blot analysis. RESULTS: Like patients with MH/EHS, Casq1-KO and Casq1-CKO mice had faster basal heart rate and ventricular tachycardia on exposure to 2% isoflurane, which could be relieved by dantrolene. Basal sinus tachycardia and ventricular ectopic electric triggering also occurred in Casq1-KO hearts ex vivo. Accordingly, the ventricular cardiomyocytes from Casq1-CKO mice displayed dantrolene-sensitive increased Ca2+ waves and diastole premature Ca2+ transients/oscillations on isoflurane. Neonatal rat ventricular myocytes with Casq1-knockdown had enhanced spontaneous Ca2+ sparks/transients on isoflurane, whereas cells overexpressing Casq1 exhibited decreased Ca2+ sparks/transients that were absent in cells with truncation of 9 amino acids at the C terminus of Casq1. Structural evaluation showed that most of the Casq1 protein was present as a polymer and physically interacted with ryanodine receptor-2 in the ventricular sarcoplasmic reticulum. The Casq1 isoform was also expressed in human myocardium. Mechanistically, exposure to 2% isoflurane or heating at 41 °C induced Casq1 oligomerization in mouse ventricular and skeletal muscle tissues, leading to a reduced Casq1/ryanodine receptor-2 interaction and increased ryanodine receptor-2 activity in the ventricle. CONCLUSIONS: Casq1 is expressed in the heart, where it regulates sarcoplasmic reticulum Ca2+ release and heart rate. Casq1 deficiency independently causes MH/EHS-like ventricular arrhythmia by trigger-induced Casq1 oligomerization and a relief of its inhibitory effect on ryanodine receptor-2-mediated Ca2+ release, thus revealing a new inherited arrhythmia and a novel mechanism for MH/EHS arrhythmogenesis.
引用
- Sun Z, Wang L, Han L, et al. Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia. Circulation. 2021. PMID: 34162222. doi:10.1161/CIRCULATIONAHA.121.053255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。